If a medtech startup doesn’t define its brand, competitors and customers will do it for it. That was the warning from a branding panel at LSI USA ’26. Brand, the panelists argued, is far more than a logo, color palette, or pitch deck. For an early-stage device company, it is the combination of mission, positioning, credibility, and consistency that customers, investors, employees, and partners experience.
Rachel Knutton, CEO of Alluvia Studio, moderated the conversation with Amanda DePalma, SVP of Ultrasound Global Marketing at Siemens Healthineers, and Terri Burke, Senior Partner at Intuitive Ventures. Their shared view: brand work should start well before a company is ready to launch.
Brand Is Strategy Before It Is Design
Burke pushed back on the idea that brand begins with visual identity. In her view, brand starts with the questions that come first: What problem are you solving? What is your value proposition? How are you positioned, and what makes you unique?
Answering those questions is what makes a company credible, relevant, and distinct. A logo can express the brand later, but it cannot supply the substance.
DePalma defined brand as the promise a company makes to its customers, one they experience both functionally and emotionally. In medtech, that promise is tested at every touchpoint: the website, the packaging, the sales call, the complaint process, and the clinical encounter.
Each of those interactions, she said, either strengthens how customers see the brand or erodes it.
Why Positioning Work Comes First
Knutton described Alluvia Studio’s process as “define, refine, shine,” with the heaviest lifting in the first stage. Defining the brand is the unglamorous work of deciding who the company is, whom it serves, what it stands for, and why the market should care.
Burke said this stage matters most for startups because it shapes how investors understand the business from the first meeting: who the team is, what value it brings, and why an investor should care.
Startups do not need every answer on day one. Burke urged teams to test their positioning with real customers and physicians, then adjust the story based on what resonates.
The discipline is keeping claims, positioning, and evidence aligned. If a company promises to save time, reduce burden, or improve outcomes, it needs a plan to prove that promise.
Consistency Turns a Promise into Trust
Brand discipline gets harder as a company grows, and more important. DePalma said the message has to be simple enough for everyone in the organization to repeat it. If it is not, customers get confused and results suffer.
That consistency starts internally. DePalma pointed to the Siemens Healthineers purpose statement, which the company uses in both internal and external communications, as a tool teams can return to in hard moments to ask whether a decision reflects their values.
Knutton called values a company’s north star. They guide decisions, attract the right people and partners, and keep a team grounded as the business changes. They may sound soft, she said, but they set a company apart.
Own a Category Instead of Chasing Competitors
The most practical lesson came from Burke’s time at Edwards Lifesciences, working on the product that became the Edwards Intuity valve. Competitors were calling similar products “sutureless,” but the team sensed that label did not capture what made their valve valuable.
A cardiac surgeon supplied the answer by describing it as a rapid deployment valve. That reframing let Edwards define a new category rather than spend its energy explaining how it differed from existing products.
The takeaway for startups: strong positioning comes from understanding what customers value most, not from leading with technical specifications.
Build a Claims Road Map Early
In medtech, brand claims are only as strong as the evidence behind them. DePalma recommended building a claims matrix long before launch, so the whole team knows what the company will need to prove and works toward it together.
Burke noted that investors do not expect early-stage companies to have all the evidence yet. They do want to see that the team knows which claims it intends to make at launch. That road map signals strategic thinking and shows the company understands how product development, clinical evidence, regulatory strategy, and commercial positioning connect.
Define Your Brand, or the Market Will
The panel’s title made the core point. No company avoids being branded. The only choice is whether it shapes that brand itself.
DePalma warned that companies that do not decide where they want to play and what they stand for will find competitors telling that story for them.
Burke compared it to a job interview: a candidate can make the case for why they fit, or leave the interviewer to fill in the blanks. Startups face the same choice, and the market will fill in whatever they leave out.
Key Takeaways
- Medical device brand strategy starts with positioning and purpose; visual identity comes later.
- Early definition work shapes how investors, customers, and partners understand a startup from the first conversation.
- Consistent internal messaging is what makes an external brand promise credible.
- The strongest position is often a new category the company can own, not a comparison with incumbents.
- A claims road map connects product development, clinical evidence, and regulatory strategy to what the company will say at launch.
For medtech startups, branding is not decoration. It explains a company’s purpose, supports its claims, aligns its team, and earns market trust. Founders who do this work early show up with clarity at every stage, from the first pitch to an acquisition conversation. Meet the investors and strategics who will hear that pitch at LSI USA ’27, March 15 to 19, 2027, in Dana Point, California.